1 / 19

A presentation to January 27, 2011

A presentation to January 27, 2011. Exclusive North American Manufacturer of. 1. Regulatory Compliance.

acosta
Download Presentation

A presentation to January 27, 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A presentation to January 27, 2011 Exclusive North American Manufacturer of 1

  2. Regulatory Compliance MFStek products are manufactured in-house under Health Canada GMP protocols and also operates under ISO9001 and ISO 14001 standards. The MFStek Regulatory Department works with international regulatory boards to ensure compliance and to secure all appropriate approvals (below), when and where possible. Due to the advanced nature of MFStek nanotechnology surface coatings, Federal Government Departments (i.e. Health Canada, Canadian Food Inspection Agency, United States EPA, EPA DfE and FDA) do not always have published evaluation protocols. When this occurs, MFStek secures compliant approvals and ensures that all products are labelled according to international standards. It is not the intention of MFStek to circumvent any regulatory approvals and make claims that are non-compliant with local or international law. Therefore, the information provided throughout this presentation has been quantified by international 3rd party organizations and when possible Federal Government entities (i.e. DIN, CFIA).

  3. Nano Glass Product Lines

  4. Product Manufacturing and QA ISO 9001 / ISO 14001 Health Canada GMP License Formats: 70ml - 22,000L Tankers Regulatory Packaging / Marketing Microbiology & Quality Control Certification of Analysis Custom Packaging & Kits

  5. MFStek Capabilities MFStek designs and manufactures nanotechnology surface coating materials, OEM additives and sustainable industrial chemicals. Products include but are not limited to: SIGMAtek: Nano-scale coating materials (<100nm) NanoCoat: Pigmented & non-pigmented coatings (2 - 200 microns) PUREtek: Biodegradable, self-catalyzing/cancelling water remediation additives. Customized industrial chemicals.

  6. Easy-to-clean Properties

  7. 5

  8. Bacoban Summary Bacoban is a water based daily cleaner and disinfectant that establishes an easy-to-clean nano-thin layer which prevents the adhesion of pollutants. Infused government approved antimicrobial biocides allow the layer to actively destroy germs for 10-days (quantified by third party laboratories). Easy-to-clean Properties Surface Preservation Residual Antimicrobial Effect Closing the ‘Hygienic Gap’

  9. Easy-to-clean Properties Bacoban establishes a nano-scale coating on non-absorbent / non-porous surfaces. The layer renders the surface easy-to-clean via an alteration of surface energy, reducing the amount of time and chemicals required to clean a surface. SGS Laboratories Reduction in cleaning time Reduction in chemicals Cleaner & Disinfectant

  10. Easy-to-clean Properties

  11. Efficacy Testing

  12. 3D Coating Matrix with Biocide Self-organizing 3D Matrix Unified easy-to-clean layer Breathable structure Cross-linked for durability Sponge effect on biocides Locked-in antimicrobial

  13. Controlled Release Mechanism C B A

  14. Hygienic Gap Closing the Hygienic Gap 100 90 80 70 60 50 40 30 20 10 0 Direct drop in the effect after evaporation of the disinfectant Disinfection Disinfection Degree of effectiveness Time

  15. Closing the Hygienic Gap

  16. Untreated Surface Treated Surface Canadian HealthCare Testing • Staphylococcus Warneri 13 to 4 CFU/swab ↓ 69% • Staphylococcus Hominis Subsp. 7 to 0 CFU/swab ↓100% • Staphylococcus Capitis 4 to 1 CFU/swab ↓75%

  17. Formats & Equipment

  18. Certification & Documentation Global Aviation Approvals Biocompatibility Certificates Regulatory Approvals 3rd Party Efficacy Data (SGS) Clinical Trials Research Papers Technical Data Sheets Material Safety Data Sheets

  19. Thank You - Questions Please True residual antimicrobial efficacy

More Related